ARCHIVE

• BULLETIN
  August 25, 2003

• Korosho Collects Data to Decide Reevaluation of Gastric Ulcer, Cataract Drugs
  August 25, 2003

• Financial Results in 1st Quarter
  August 25, 2003

• GERD Add. Indication to Boost Sales of Pariet: Eisai
  August 25, 2003

• Fujisawa Endows Chair of Theoretical Drug Design
  August 25, 2003

• BULLETIN
  August 25, 2003

• Takeda Assesses Intellectual Property Management Based on Costs, Benefits
  August 25, 2003

• JST Outsources 4 High-risk Projects to Companies
  August 25, 2003

• REGULATORY NEWS IN BRIEF
  August 25, 2003

• JT Positions Pharma Business as Pillar in Next Generation
  August 25, 2003

• TRI to Increase Staff Members to 150: Seminar
  August 25, 2003

• Wives in Their 20s Having Greater Number of Children: Survey
  August 25, 2003

• August 25, 2003

• PRESS SEMINAR
  August 25, 2003

• 31 Mono-drugs, 7 Combination Drugs Designated for Quality Reevaluation
  August 25, 2003

• Yamanouchi to Beef Up Marketing to Gain 6% Share: President Takenaka
  August 25, 2003

• DIAGNOSTIC NEWS IN BRIEF
  August 25, 2003

• 31 Ingredients Designated for 26th Quality Reevaluation
  August 25, 2003

• Shionogi Places Top Priority on Proper Use in Marketing Opioids for Cancer Pain
  August 25, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  August 25, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 580
• 581
• 582
• 583
• 584
• 585
• 586
• 587
• 588
• …
• Next ›
• 最終 »